A Second p53 Binding Site in the Central Domain of Mdm2 Is Essential for p53 Ubiquitination
Jianhong Ma(GlaxoSmithKline (United Kingdom)), Zhihong Lai(South College), Kurt A. Auger(Maryville College), Kyung Johanson(South College), John D. Martin(Harvard University), Robert B. Kirkpatrick(Protein Express (United States)), Robert A. Copeland(Unknown), Peter J. Tummino(Intarcia Therapeutics (United States)), Hong Zhang(Huaibei Normal University), Thau Ho(GlaxoSmithKline (United States)), Michael Grooms(Protein Express (United States))
Cited by 0
Related Papers
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
|Journal of Biological Chemistry|1998|3k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848